Literature DB >> 31872939

Real-World Evidence in Oncology: Opportunities and Limitations.

Massimo Di Maio1, Francesco Perrone2, Pierfranco Conte3.   

Abstract

Keywords:  Cancer treatments; Clinical trials; Real-world evidence

Mesh：

Year:  2019        PMID： 31872939      PMCID： PMC7216461          DOI： 10.1634/theoncologist.2019-0647

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  29 in total

1.  Can it work? Does it work? Is it worth it? The testing of healthcareinterventions is evolving.

Authors:  B Haynes
Journal:  BMJ       Date:  1999-09-11

Review 2.  Relevance of randomised controlled trials in oncology.

Authors:  Ian F Tannock; Eitan Amir; Christopher M Booth; Saroj Niraula; Alberto Ocana; Bostjan Seruga; Arnoud J Templeton; Francisco Vera-Badillo
Journal:  Lancet Oncol       Date:  2016-12       Impact factor: 41.316

3.  Trastuzumab emtansine for HER2-positive advanced breast cancer.

Authors:  Sunil Verma; David Miles; Luca Gianni; Ian E Krop; Manfred Welslau; José Baselga; Mark Pegram; Do-Youn Oh; Véronique Diéras; Ellie Guardino; Liang Fang; Michael W Lu; Steven Olsen; Kim Blackwell
Journal:  N Engl J Med       Date:  2012-10-01       Impact factor: 91.245

4.  Real-World or Controlled Clinical Trial Data in Real-World Practice.

Authors:  Ting-Hui Wu; James Chih-Hsin Yang
Journal:  J Thorac Oncol       Date:  2018-04       Impact factor: 15.609

5.  From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Authors:  Giulia Pasello; Giovanni Vicario; Fable Zustovich; Francesco Oniga; Stefania Gori; Francesco Rosetti; Andrea Bonetti; Adolfo Favaretto; Silvia Toso; Roberta Redelotti; Antonio Santo; Daniele Bernardi; Petros Giovanis; Cristina Oliani; Lorenzo Calvetti; Carlo Gatti; Giovanni Palazzolo; Zora Baretta; Alberto Bortolami; Laura Bonanno; Marco Basso; Jessica Menis; Donatella Da Corte; Stefano Frega; Valentina Guarneri; PierFranco Conte
Journal:  Oncologist       Date:  2019-03-07

6.  Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Authors:  David M Hyman; Igor Puzanov; Vivek Subbiah; Jason E Faris; Ian Chau; Jean-Yves Blay; Jürgen Wolf; Noopur S Raje; Eli L Diamond; Antoine Hollebecque; Radj Gervais; Maria Elena Elez-Fernandez; Antoine Italiano; Ralf-Dieter Hofheinz; Manuel Hidalgo; Emily Chan; Martin Schuler; Susan Frances Lasserre; Martina Makrutzki; Florin Sirzen; Maria Luisa Veronese; Josep Tabernero; José Baselga
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245

7.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Authors:  Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Rongcheng Luo; Jifeng Feng; Shenglong Ye; Tsai-Sheng Yang; Jianming Xu; Yan Sun; Houjie Liang; Jiwei Liu; Jiejun Wang; Won Young Tak; Hongming Pan; Karin Burock; Jessie Zou; Dimitris Voliotis; Zhongzhen Guan
Journal:  Lancet Oncol       Date:  2008-12-16       Impact factor: 41.316

8.  Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.

Authors:  Michael P Lux; Naiba Nabieva; Andreas D Hartkopf; Jens Huober; Bernhard Volz; Florin-Andrei Taran; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Lothar Häberle; Johannes Ettl; Diana Lüftner; Markus Wallwiener; Volkmar Müller; Matthias W Beckmann; Erik Belleville; Pauline Wimberger; Carsten Hielscher; Matthias Geberth; Wolfgang Abenhardt; Christian Kurbacher; Rachel Wuerstlein; Christoph Thomssen; Michael Untch; Peter A Fasching; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Andreas Schneeweiss; Sara Y Brucker
Journal:  Cancers (Basel)       Date:  2018-12-21       Impact factor: 6.639

9.  Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.

Authors:  Hanna K Sanoff; YunKyung Chang; Jennifer L Lund; Bert H O'Neil; Stacie B Dusetzina
Journal:  Oncologist       Date:  2016-05-16

10.  Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study.

Authors:  Martin Boegemann; Sara Khaksar; Guillaume Bera; Alison Birtle; Catherine Dopchie; Louis-Marie Dourthe; Els Everaert; Martin Hatzinger; Dirko Hercher; Werner Hilgers; Geoffrey Matus; Laura Garcia Alvarez; Laurent Antoni; Martin Lukac; Geneviève Pissart; Paul Robinson; Tony Elliott
Journal:  BMC Cancer       Date:  2019-01-14       Impact factor: 4.430
View more
  21 in total

1.  Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.

Authors:  Laura Bonanno; Alberto Pavan; Alessandra Ferro; Lorenzo Calvetti; Stefano Frega; Giulia Pasello; Giuseppe Aprile; Valentina Guarneri; PierFranco Conte
Journal:  Oncologist       Date:  2020-07-07

2.  A platform for continuous learning in oncology.

Authors:  Joseph O Deasy; Peter D Stetson
Journal:  Nat Cancer       Date:  2021-07

3.  Accuracy of Electronic Medical Record Follow-Up Data for Estimating the Survival Time of Patients With Cancer.

Authors:  Michael F Gensheimer; Balasubramanian Narasimhan; A Solomon Henry; Douglas J Wood; Daniel L Rubin
Journal:  JCO Clin Cancer Inform       Date:  2022-06

4.  Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer.

Authors:  Sunny Guin; Tomi Jun; Vaibhav G Patel; Kristin L Ayers; Matthew Deitz; Yuqin Cai; Xiang Zhou; Che-Kai Tsao; William K Oh; Rong Chen; Bobby C Liaw
Journal:  JCO Clin Cancer Inform       Date:  2022-06

5.  Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy.

Authors:  Jue Hou; Rachel Zhao; Tianrun Cai; Brett Beaulieu-Jones; Thany Seyok; Kumar Dahal; Qianyu Yuan; Xin Xiong; Clara-Lea Bonzel; Claire Fox; David C Christiani; Thomas Jemielita; Katherine P Liao; Kai-Li Liaw; Tianxi Cai
Journal:  JAMA Netw Open       Date:  2022-06-01

6.  Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in Italy.

Authors:  Massimo Breccia; Francesca Chiodi; Aurelio Pio Nardozza; Diletta Valsecchi; Valentina Perrone; Diego Sangiorgi; Elisa Giacomini; Maria Chiara Rendace; Paola Coco; Eleonora Premoli; Luca Degli Esposti
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

7.  PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.

Authors:  Laura Pizzuti; Eriseld Krasniqi; Isabella Sperduti; Maddalena Barba; Teresa Gamucci; Maria Mauri; Enzo Maria Veltri; Icro Meattini; Rossana Berardi; Francesca Sofia Di Lisa; Clara Natoli; Mirco Pistelli; Laura Iezzi; Emanuela Risi; Nicola D'Ostilio; Silverio Tomao; Corrado Ficorella; Katia Cannita; Ferdinando Riccardi; Alessandra Cassano; Emilio Bria; Maria Agnese Fabbri; Marco Mazzotta; Giacomo Barchiesi; Andrea Botticelli; Giuliana D'Auria; Anna Ceribelli; Andrea Michelotti; Antonio Russo; Beatrice Taurelli Salimbeni; Giuseppina Sarobba; Francesco Giotta; Ida Paris; Rosa Saltarelli; Daniele Marinelli; Domenico Corsi; Elisabetta Maria Capomolla; Valentina Sini; Luca Moscetti; Lucia Mentuccia; Giuseppe Tonini; Mimma Raffaele; Luca Marchetti; Mauro Minelli; Enzo Maria Ruggeri; Paola Scavina; Olivia Bacciu; Nello Salesi; Lorenzo Livi; Nicola Tinari; Antonino Grassadonia; Angelo Fedele Scinto; Rosalinda Rossi; Maria Rosaria Valerio; Elisabetta Landucci; Simonetta Stani; Beatrice Fratini; Marcello Maugeri-Saccà; Michele De Tursi; Angela Maione; Daniele Santini; Armando Orlandi; Vito Lorusso; Enrico Cortesi; Giuseppe Sanguineti; Paola Pinnarò; Federico Cappuzzo; Lorenza Landi; Claudio Botti; Federica Tomao; Sonia Cappelli; Giulia Bon; Fabio Pelle; Flavia Cavicchi; Elena Fiorio; Jennifer Foglietta; Simone Scagnoli; Paolo Marchetti; Gennaro Ciliberto; Patrizia Vici
Journal:  Ther Adv Med Oncol       Date:  2021-11-29       Impact factor: 8.168

8.  Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center.

Authors:  Marija Ivanović; Lea Knez; Ana Herzog; Mile Kovačević; Tanja Cufer
Journal:  Oncologist       Date:  2021-08-02

9.  A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer.

Authors:  Rana R McKay; Jason M Hafron; Christine Ferro; Helen M Wilfehrt; Kate Fitch; Scott C Flanders; Michael D Fabrizio; Michael T Schweizer
Journal:  Adv Ther       Date:  2020-10-07       Impact factor: 3.845

10.  Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.

Authors:  Ying Zheng; Ruth Kim; Ting Yu; Julie A Gayle; Christina L Wassel; Jill Dreyfus; Hemant Phatak; Saby George
Journal:  Oncologist       Date:  2021-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.